Monopar Therapeutics Inc's total assets for Q3 2024 were $6.07M, a decrease of -15.46% from the previous quarter. MNPR total liabilities were $1.12M for the fiscal quarter, a 3.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.